Corcept Therapeutics Incorporated (CORT) News
Filter CORT News Items
CORT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CORT News Highlights
- CORT's 30 day story count now stands at 5.
- Over the past 17 days, the trend for CORT's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about CORT are NKTR and TOP.
Latest CORT News From Around the Web
Below are the latest news stories about CORCEPT THERAPEUTICS INC that investors may wish to consider to help them evaluate CORT as an investment opportunity.
Corcept Therapeutics Inc's Chief Development Officer Sells SharesOn December 22, 2023, Chief Development Officer William Guyer sold 10,000 shares of Corcept Therapeutics Inc (NASDAQ:CORT), as reported in a recent SEC Filing. |
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Could Be 36% Below Their Intrinsic Value EstimateKey Insights Corcept Therapeutics' estimated fair value is US$41.23 based on 2 Stage Free Cash Flow to Equity Corcept... |
Here's Why Corcept Therapeutics (CORT) is a Strong Momentum StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Insider Sell: Joseph Lyon of Corcept Therapeutics Inc (CORT) Sells 5,000 SharesJoseph Lyon, the Chief Accounting Officer of Corcept Therapeutics Inc, has recently made a significant stock transaction, selling 5,000 shares of the company on December 4, 2023. |
Why Is Corcept (CORT) Up 0.7% Since Last Earnings Report?Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Should Weakness in Corcept Therapeutics Incorporated's (NASDAQ:CORT) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?Corcept Therapeutics (NASDAQ:CORT) has had a rough three months with its share price down 19%. However, the company's... |
7 Underappreciated Biotech Stocks to Pick Up on the CheapAmid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. |
Insider Sell: Chief Accounting Officer Joseph Lyon Sells 5,000 Shares of Corcept Therapeutics IncOn November 2, 2023, Joseph Lyon, the Chief Accounting Officer of Corcept Therapeutics Inc (NASDAQ:CORT), sold 5,000 shares of the company. |
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2023 Earnings Call TranscriptCorcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2023 Earnings Call Transcript November 1, 2023 Operator: Good day. And welcome to the Corcept Therapeutics Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded. I […] |